Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) Stock Competitors & Peer Comparison
See (BBNX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BBNX | $10.76 | -6.60% | 477.6M | -5.94 | -$1.81 | N/A |
| SIRO | $109.97 | +0.00% | 22B | N/A | N/A | N/A |
| HIMS | $19.38 | -7.09% | 4.3B | 38.08 | $0.51 | N/A |
| NVST | $24.60 | -4.80% | 4B | 87.84 | $0.28 | N/A |
| CON | $21.12 | -2.67% | 2.7B | 16.25 | $1.30 | +1.18% |
| CV | $7.51 | -0.27% | 351.8M | -15.65 | -$0.48 | N/A |
| NAKA | $0.23 | -5.75% | 85.1M | -0.16 | -$1.41 | N/A |
| KDLY | $11.30 | +1.16% | 68.1M | -15.48 | -$0.73 | N/A |
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
| PARK | $16.34 | +2.96% | 31.8M | -90.78 | -$0.18 | N/A |
Stock Comparison
BBNX vs SIRO Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, BBNX is priced at $10.76, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas SIRO's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, BBNX is more volatile compared to SIRO. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check SIRO's competition here
BBNX vs HIMS Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, HIMS has a market cap of 4.3B. Regarding current trading prices, BBNX is priced at $10.76, while HIMS trades at $19.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas HIMS's P/E ratio is 38.08. In terms of profitability, BBNX's ROE is -0.24%, compared to HIMS's ROE of +0.23%. Regarding short-term risk, BBNX is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check HIMS's competition here
BBNX vs NVST Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, NVST has a market cap of 4B. Regarding current trading prices, BBNX is priced at $10.76, while NVST trades at $24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas NVST's P/E ratio is 87.84. In terms of profitability, BBNX's ROE is -0.24%, compared to NVST's ROE of +0.02%. Regarding short-term risk, BBNX is more volatile compared to NVST. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check NVST's competition here
BBNX vs CON Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, CON has a market cap of 2.7B. Regarding current trading prices, BBNX is priced at $10.76, while CON trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas CON's P/E ratio is 16.25. In terms of profitability, BBNX's ROE is -0.24%, compared to CON's ROE of +0.47%. Regarding short-term risk, BBNX is more volatile compared to CON. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check CON's competition here
BBNX vs CV Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, CV has a market cap of 351.8M. Regarding current trading prices, BBNX is priced at $10.76, while CV trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas CV's P/E ratio is -15.65. In terms of profitability, BBNX's ROE is -0.24%, compared to CV's ROE of +1.05%. Regarding short-term risk, BBNX is less volatile compared to CV. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check CV's competition here
BBNX vs NAKA Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, NAKA has a market cap of 85.1M. Regarding current trading prices, BBNX is priced at $10.76, while NAKA trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas NAKA's P/E ratio is -0.16. In terms of profitability, BBNX's ROE is -0.24%, compared to NAKA's ROE of -0.74%. Regarding short-term risk, BBNX is less volatile compared to NAKA. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check NAKA's competition here
BBNX vs KDLY Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, BBNX is priced at $10.76, while KDLY trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas KDLY's P/E ratio is -15.48. In terms of profitability, BBNX's ROE is -0.24%, compared to KDLY's ROE of -0.74%. Regarding short-term risk, BBNX is more volatile compared to KDLY. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check KDLY's competition here
BBNX vs NEUE Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, BBNX is priced at $10.76, while NEUE trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas NEUE's P/E ratio is -0.38. In terms of profitability, BBNX's ROE is -0.24%, compared to NEUE's ROE of +0.22%. Regarding short-term risk, BBNX is more volatile compared to NEUE. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check NEUE's competition here
BBNX vs PARK Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, PARK has a market cap of 31.8M. Regarding current trading prices, BBNX is priced at $10.76, while PARK trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas PARK's P/E ratio is -90.78. In terms of profitability, BBNX's ROE is -0.24%, compared to PARK's ROE of -67.96%. Regarding short-term risk, BBNX is more volatile compared to PARK. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check PARK's competition here
BBNX vs BRK Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, BRK has a market cap of 11.6M. Regarding current trading prices, BBNX is priced at $10.76, while BRK trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas BRK's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to BRK's ROE of N/A. Regarding short-term risk, BBNX is more volatile compared to BRK. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check BRK's competition here
BBNX vs PFSA Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, PFSA has a market cap of 264.3K. Regarding current trading prices, BBNX is priced at $10.76, while PFSA trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas PFSA's P/E ratio is -0.01. In terms of profitability, BBNX's ROE is -0.24%, compared to PFSA's ROE of +0.90%. Regarding short-term risk, BBNX is less volatile compared to PFSA. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check PFSA's competition here
BBNX vs SPAN Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, SPAN has a market cap of 0. Regarding current trading prices, BBNX is priced at $10.76, while SPAN trades at $29.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas SPAN's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, BBNX is less volatile compared to SPAN. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check SPAN's competition here
BBNX vs STJ Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, STJ has a market cap of 0. Regarding current trading prices, BBNX is priced at $10.76, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas STJ's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to STJ's ROE of +0.21%. Regarding short-term risk, BBNX is more volatile compared to STJ. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check STJ's competition here
BBNX vs EXAC Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, EXAC has a market cap of 0. Regarding current trading prices, BBNX is priced at $10.76, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas EXAC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, BBNX is more volatile compared to EXAC. This indicates potentially higher risk in terms of short-term price fluctuations for BBNX.Check EXAC's competition here
BBNX vs MEDC Comparison April 2026
BBNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BBNX stands at 477.6M. In comparison, MEDC has a market cap of 0. Regarding current trading prices, BBNX is priced at $10.76, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BBNX currently has a P/E ratio of -5.94, whereas MEDC's P/E ratio is N/A. In terms of profitability, BBNX's ROE is -0.24%, compared to MEDC's ROE of N/A. Regarding short-term risk, BBNX is less volatile compared to MEDC. This indicates potentially lower risk in terms of short-term price fluctuations for BBNX.Check MEDC's competition here